Cellular stress triggers TEL nuclear export via two genetically separable pathways

Journal of Cellular Biochemistry

Volumn 104, Issue 2, 2008, Pages 488-498

  Hanson, Caroline A ^a,b   Wood, Lauren D ^a,b,c   Hiebert, Scott W ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c NONE   (United States)

Author keywords

Cellular stress; ETV6; Nuclear export; Repression; TEL; Transcription

Indexed keywords

TRANSCRIPTION FACTOR ETV6;

ARTICLE; CELL STRESS; CYTOPLASM; IN VITRO STUDY; NUCLEAR EXPORT SIGNAL; OSMOTIC STRESS; PHOSPHORYLATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SUMOYLATION;

3T3 CELLS; ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CYTOPLASM; MICE; OSMOTIC PRESSURE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS;

EID: 43449091585     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21637     Document Type: Article

References (45)

1. Arai H, Maki K, Waga K, Sasaki K, Nakamura Y, Imai Y, Kurokawa M, Hirai H, Mitani K. 2002. Functional regulation of TEL by p38-induced phosphorylation. Biochem Biophys Res Commun 299:116-125.
2. Chakrabarti SR, Nucifora G. 1999. The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A. Biochem Biophys Res Commun 264:871-877.
3. Chakrabarti SR, Sood R, Ganguly S, Bohlander S, Shen Z, Nucifora G. 1999. Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9. Proc Natl Acad Sci USA 96:7467-7472.
4. Chakrabarti SR, Sood R, Nandi S, Nucifora G. 2000. Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies. Proc Natl Acad Sci USA 97:13281-13285.
5. Cruzalegui FH, Hardingham GE, Bading H. 1999. c-Jun functions as a calcium-regulated transcriptional activator in the absence of JNK/SAPK1 activation. EMBO J 18:1335-1344.
6. Enslen H, Raingeaud J, Davis RJ. 1998. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and M KK6. J Biol Chem 273:1741-1748.
7. Fenrick R, Amann JM, Lutterbach B, Wang L, Westendorf JJ, Downing JR, Hiebert SW. 1999. Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein. Mol Cell Biol 19:6566-6574.
8. Fenrick R, Wang L, Nip J, Amann JM, Rooney RJ, Walker-Daniels J, Crawford HC, Hulboy DL, Kinch MS, Matrisian LM, Hiebert SW. 2000. TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1. Mol Cell Biol 20:5828-5839.
9. Golub TR, Barker GF, Lovett M, Gilliland DG. 1994. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307-316.
10. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG. 1995. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 92:4917-4921.
11. Golub TR, Barker GF, Stegmaier K, Gilliland DG. 1996a. Involvement of the TEL gene in hematologic malignancy by diverse molecular genetic mechanisms. Curr Top Microbiol Immunol 211:279-288.
12. Golub TR, Goga A, Barker GF, Afar DE, McLaughlin J, Bohlander SK, Rowley JD, Witte ON, Gilliland DG. 1996b. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol Cell Biol 16:4107-4116.
13. Guidez F, Petrie K, Ford AM, Lu H, Bennett CA, MacGregor A, Hannemann J, Ito Y, Ghysdael J, Greaves M, Wiedemann LM, Zelent A. 2000. Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein. Blood 96:2557-2561.
14. Han J, Wang X, Jiang Y, Ulevitch RJ, Lin S. 1997. Identification and characterization of a predominant isoform of human M KK3. FEBS Lett 403:19-22.
15. Hatta Y, Takeuchi S, Yokota J, Koeffler HP. 1997. Ovarian cancer has frequent loss of heterozygosity at chromosome 12p12. 3-13.1 (region of TEL and Kip1 loci) and chromosome 12q23-ter: Evidence for two new tumour-suppressor genes. Br J Cancer 75:1256-1262.
16. Hiebert SW, Sun W, Davis JN, Golub T, Shurtleff S, Buijs A, Downing JR, Grosveld G, Roussell MF, Gilliland DG, Lenny N, Meyers S. 1996. The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol Cell Biol 16:1349-1355.
17. Ho JM, Beattie BK, Squire JA, Frank DA, Barber DL. 1999. Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling. Blood 93:4354-4364.
18. Hsu T, Trojanowska M, Watson DK. 2004. Ets proteins in biological control and cancer. J Cell Biochem 91:896-903.
19. Irvin BJ, Wood LD, Wang L, Fenrick R, Sansam CG, Packham G, Kinch M, Yang E, Hiebert SW. 2003. TEL, a putative tumor suppressor, induces apoptosis and represses transcription of Bcl-XL. J Biol Chem 278:46378-46386.
20. Janknecht R, Nordheim A. 1996. MAP kinase-dependent transcriptional coactivation by Elk-1 and its cofactor CBP. Biochem Biophys Res Commun 228:831-837.
21. Kim CA, Phillips ML, Kim W, Gingery M, Tran HH, Robinson MA, Faham S, Bowie JU. 2001. Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression. EMBO J 20:4173-4182.
22. Lacronique V, Boureux A, Monni R, Dumon S, Mauchauffe M, Mayeux P, Gouilleux F, Berger R, Gisselbrecht S, Ghysdael J, Bernard OA. 2000. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells. Blood 95:2076-2083.
23. Li QJ, Yang SH, Maeda Y, Sladek FM, Sharrocks AD, Martins-Green M. 2003. MAP kinase phosphorylation-dependent activation of Elk-1 leads to activation of the co-activator p300. EMBO J 22:281-291.
24. Lopez RG, Carron C, Oury C, Gardellin P, Bernard O, Ghysdael J. 1999. TEL is a sequence-specific transcriptional repressor. J Biol Chem 274:30132-30138.
25. Lopez RG, Carron C, Ghysdael J. 2003. v-SRC specifically regulates the nucleo-cytoplasmic delocalization of the major isoform of TEL (ETV6). J Biol Chem 278:41316-41325.
26. Ludwig S, Hoffmeyer A, Goebeler M, Kilian K, Hafner H, Neufeld B, Han J, Rapp UR. 1998. The stress inducer arsenite activates mitogen-activated protein kinases extracellular signal-regulated kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway. J Biol Chem 273:1917-1922.
27. Maki K, Arai H, Waga K, Sasaki K, Nakamura F, Imai Y, Kurokawa M, Hirai H, Mitani K. 2004. Leukemia-related transcription factor TEL is negatively regulated through extracellular signal-regulated kinase-induced phosphorylation. Mol Cell Biol 24:3227-3237.
28. Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM. 1995. The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res 55:34-38.
29. Peeters P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P, Monpoux F, Van Rompaey L, Baens M, Van den Berghe H, Marynen P. 1997. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood 90:2535-2540.
30. Poirel H, Lopez RG, Lacronique V, Della Valle V, Mauchauffe M, Berger R, Ghysdael J, Bernard OA. 2000. Characterization of a novel ETS gene, TELB, encoding a protein structurally and functionally related to TEL. Oncogene 19:4802-4806.
31. Potter MD, Buijs A, Kreider B, van Rompaey L, Grosveld GC. 2000. Identification and characterization of a new human ETS-family transcription factor, TEL2, that is expressed in hematopoietic tissues and can associate with TEL1/E TV6. Blood 95:3341-3348.
32. Raynaud S, Cave H, Baens M, Bastard C, Cacheux V, Grosgeorge J, Guidal-Giroux C, Guo C, Vilmer E, Marynen P, Grandchamp B. 1996. The 12;21 translocation involving TEL and deletion of the other TEL allele: Two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 87:2891-2899.
33. Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA. 1995a. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 85:3662-3670.
34. Romana SP, Poirel H, Leconiat M, Flexor MA, Mauchauffe M, Jonveaux P, Macintyre EA, Berger R, Bernard OA. 1995b. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 86:4263-4269.
35. Roux PP, Blenis J. 2004. ERK and p38 MAPK-activated protein kinases: A family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68:320-344.
36. Schwaller J, Frantsve J, Aster J, Williams IR, Tomasson MH, Ross TS, Peeters P, Van Rompaey L, Van Etten RA, Ilaria R, Jr., Marynen P, Gilliland DG. 1998. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes. EMBO J 17:5321-5333.
37. Sevilla L, Zaldumbide A, Carlotti F, Dayem MA, Pognonec P, Boulukos KE. 2001. Bcl-XL expression correlates with primary macrophage differentiation, activation of functional competence, and survival and results from synergistic transcriptional activation by Ets2 and PU.1. J Biol Chem 276:17800-17807.
38. Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan GC, Pui CH, Grosveld G, Downing JR. 1995. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 9:1985-1989.
39. Treinies I, Paterson HF, Hooper S, Wilson R, Marshall CJ. 1999. Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal to stimulate DNA synthesis. Mol Cell Biol 19:321-329.
40. Van Rompaey L, Dou W, Buijs A, Grosveld G. 1999. Tel, a frequent target of leukemic translocations, induces cellular aggregation and influences expression of extracellular matrix components. Neoplasia 1:526-536.
41. Wang L, Hiebert SW. 2001. TEL contacts multiple compressors and specifically associates with histone deacetylase-3. Oncogene 20:3716-3725.
42. Wasylyk B, Hagman J, Gutierrez-Hartmann A. 1998. Ets transcription factors: Nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem Sci 23:213-216.
43. Wood LD, Irvin BJ, Nucifora G, Luce KS, Hiebert SW. 2003. Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor. Proc Natl Acad Sci USA 100:3257-3262.
44. Yang BS, Hauser CA, Henkel G, Colman MS, Van Beveren C, Stacey KJ, Hume DA, Maki RA, Ostrowski MC. 1996. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol Cell Biol 16:538-547.
45. Zhang Q, Badell IR, Schwarz EM, Boulukos KE, Yao Z, Boyce BF, Xing L. 2005. Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2. Arthritis Rheum 52:2708-2718.